A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
NCT00135655 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-05-21
Summary
The purpose of this study is to investigate the safety and tolerability of three dose strengths of the study drug in subjects with post cataract extraction macular edema.
Conditions
- Macular Edema, Cystoid
Interventions
- DRUG
-
denufosol tetrasodium (INS37217) Intravitreal Injection
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Amy Schaberg, BSN · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
More Related Trials
-
The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
NCT00358423 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study for Post op Inflammation After Cataract Surgery
NCT05665270 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
NCT00782717 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
NCT01244334 ·Status: COMPLETED ·Phase: PHASE4
-
Bromfenac Versus Dexamethasone After Cataract Surgery
NCT03317847 ·Status: COMPLETED ·Phase: PHASE4
-
Nepafenac Once Daily for Macular Edema - Study 1
NCT01853072 ·Status: COMPLETED ·Phase: PHASE3
-
Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery
NCT01326585 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
NCT05608837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery.
NCT04631315 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
NCT03025945 ·Status: COMPLETED ·Phase: NA
-
Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema
NCT02485249 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
PRevention of Macular EDema After Cataract Surgery
NCT01774474 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
NCT00494494 ·Status: COMPLETED ·Phase: PHASE4
-
Nepafenac Once Daily for Macular Edema - Study 2
NCT01872611 ·Status: COMPLETED ·Phase: PHASE3
-
Confirmatory Study Nepafenac 0.3%
NCT01109173 ·Status: COMPLETED ·Phase: PHASE3
-
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
NCT01939691 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy Comparison Study of Steroids to Control Post-operative Inflammation
NCT01801774 ·Status: UNKNOWN ·Phase: PHASE4
-
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
NCT01059955 ·Status: COMPLETED ·Phase: PHASE1
-
Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics
NCT00346983 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cataract DME - Peri vs. Intraop
NCT03920878 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
NCT04977427 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
NCT04539548 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing Double-masked Uveitis Treatment
NCT01358266 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
NCT05191706 ·Status: RECRUITING ·Phase: PHASE4
-
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT01591655 ·Status: COMPLETED ·Phase: PHASE3